In Vitro Diagnostic Tests Development & Consulting

The Point of Care (POC) and Point-of-Need (PON) diagnostic markets have gained new attention since the global SARS-CoV-2 coronavirus (COVID-19) pandemic.  The global public learned a great deal about the importance of utilizing POC or at-home laboratory tests.  Today, more laboratory diagnostic researchers and developers racing to meet the demand for assays in other potential emerging infectious diseases and particularly the on-going battle with spread of TB, STI’s, and even the re-emergence of mpox, measles and Avian flu in cattle.  In vitro diagnostic tests are the bedrock and main tool used in diagnosing pathogens, diseases in not just human, but animals, plants, and the environment.. Diagnostic tests are used not only to detect, but also used to assess immune response, predict disease severity through prognostics, monitor treatment and disease progression and to also conduct surveillance. Test, Treat, Trace.
If you are developing or considering developing a POC or PON assay or a sample collection device, reach out us for an initial assessment or strategy session.


- Partner with POCA International LLC -

Poca logo
POCA International, with 35 years of expertise is at the center of Point-of-Care Diagnostics assisting  infectious disease researchers and diagnostic test developers with its diverse expert capacities.  Whether you are looking for help with product development strategy, manufacturing partner (reagent lyophilized beads, software, analyzer, plastics), regulatory assistance or market research, commercialization strategy, we are here to partner with you toward success.

Whether your technology-Dx assay is nucleic acid, protein, Antibody or Antigen based via the numerous platform: Molecular qPCR, Isothermal (LAMP), CRISPR, Antibody (binding or neutralizing), or Antigen based, traditional or POC, diagnostic assays continue to be vital in diagnosing and treating diseases and conditions in humans, animals, and the environment.  In humans, In Vitro Diagnostic (IVD) assays contribute ~ 70% of clinical decisions.

Please contact us to assist your team in the endeavor of providing high quality, ease of use, scalable yet affordable products to fight this pandemic. If you have other exciting disruptive ideas or initiatives in vitro diagnostics, medical device and technologies to improve global health, we look forward to hearing from you.


- Get in Touch -

Thank you for your interest. Use the form below to request a consultation or to ask a question.  Give us a call: 883-762-2483